Community Connections: Navigating Lung Cancer Care into the Future
Series Sponsor
Hawai‘i is last in the nation for the early diagnosis of lung cancer. Over half of the people who are diagnosed with lung cancer will die, making lung cancer the number one cancer killer of men and women in Hawai‘i. Robotics are revolutionizing the way that we look at lung cancer diagnosis and treatment. Advances in technology allow for the quick diagnosis and treatment of lung cancer that can revolutionize the way we treat the disease.
The program will begin at 9:00 AM (Hawai'i Time).
Speaker
Taryne Imai, MD Program Director of Thoracic Surgery Queen’s University Medical Group
Dr. Taryne Imai, MD, MEHP, FACS is the Program Director of Thoracic Surgery for the Queen’s University Medical Group affiliated with the University of Hawaiʻi. She was previously the Clinical Chief of the Division of Thoracic Surgery at Cedars-Sinai Medical Center in Los Angeles California.
She is originally from Honolulu, Hawai'i where she completed her undergraduate and medical school education at the University of Hawaii at Manoa. After completing general surgery residency at Harbor-UCLA Medical Center, she went on to complete fellowships in Thoracic Surgery at the University of Pittsburgh and Surgical Critical Care at Cedars-Sinai Medical Center. Recently, in August 2021, she completed her Masters in Education for Health Professions from Johns Hopkins University.
Dr. Imai’s clinical practice specializes in robotic approaches in the treatment of benign and malignant diseases of the chest. In 2019, she was awarded the Women in Thoracic Surgery Intuitive Robotic Fellowship in advanced robotic training.
